Clinical Conundrums


Early this year, backed by a 3-year, $1.5-million grant from the Sohn Conference Foundation, Columbia University Medical Center announced plans to provide genome sequencing to all children in New York City diagnosed with high-risk cancers. The initiative is an outgrowth of Columbia’s Precision in Pediatric Sequencing (PIPseq) program, launched in 2014—the first program nationally to conduct sequencing in all of its pediatric cancer patients on diagnosis. “We now have the capability and the financial backing to have a city-wide and regional impact,” said Andrew Kung, Columbia’s chief of pediatric hematology, oncology, and stem cell transplantation and PIPseq’s director.

View PDF